STAAR Surgical Company's (NASDAQ:STAA) Stock Is Going Strong: Have Financials A Role To Play?
Wall Street Analysts Predict a 43.93% Upside in Staar Surgical (STAA): Here's What You Should Know
Returns At STAAR Surgical (NASDAQ:STAA) Appear To Be Weighed Down
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $44
Stifel analyst Thomas Stephan maintains $Staar Surgical(STAA.US)$ with a buy rating, and maintains the target price at $44.According to TipRanks data, the analyst has a success rate of 64.9% and a
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
Needham analyst David Saxon maintains $Staar Surgical(STAA.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 34.5% and a total average return of 0.7% over the
Analysts' Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA) and Repligen (RGEN)
Needham Reiterates Hold on Staar Surgical
Sidoti Events, LLC's Virtual September Small-Cap Conference
STAAR Surgical (NASDAQ:STAA) Has Some Way To Go To Become A Multi-Bagger
Baillie Gifford Reduces Stake in Staar Surgical Co
Staar Surgical Is Maintained at Buy by Stifel
Staar Surgical Price Target Cut to $44.00/Share From $50.00 by Stifel
Analyst Expectations For Staar Surgical's Future
Stifel Maintains Buy on Staar Surgical, Lowers Price Target to $44
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $44
Stifel analyst Thomas Stephan maintains $Staar Surgical(STAA.US)$ with a buy rating, and adjusts the target price from $50 to $44.According to TipRanks data, the analyst has a success rate of 66.7%
Express News | STAAR Surgical Co : Stifel Cuts Target Price to $44 From $50
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $41
CCORF analyst John Young CFA maintains $Staar Surgical(STAA.US)$ with a hold rating, and maintains the target price at $41.According to TipRanks data, the analyst has a success rate of 71.4% and a
Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)
Implied Volatility Surging for STAAR Surgical (STAA) Stock Options